Canada markets close in 4 hours 32 minutes

Cellectar Biosciences, Inc. (CLRB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.0700-0.0300 (-0.97%)
As of 11:28AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
28,211
28,211
19,220
17,586
10,141
Selling General and Administrative
10,749
10,749
9,594
6,545
5,150
Total Operating Expenses
38,961
38,961
28,814
24,131
15,290
Operating Income or Loss
-38,961
-38,961
-28,814
-24,131
-15,290
Total Other Income/Expenses Net
530
530
-
6.634
185.28
Income Before Tax
-38,043
-38,043
-28,661
-24,122
-15,094
Income Tax Expense
-60
-60
-60
0
-
Income from Continuing Operations
-37,983
-37,983
-28,601
-24,122
-15,094
Net Income
-37,983
-37,983
-28,601
-24,122
-15,094
Net Income available to common shareholders
-37,983
-37,983
-28,601
-24,122
-15,094
Basic EPS
-3.26
-3.11
-4.05
-4.35
-7.60
Diluted EPS
-3.26
-3.11
-4.05
-4.35
-7.60
Basic Average Shares
10,931
12,222
7,056
5,552
1,981
Diluted Average Shares
10,931
12,222
7,056
5,552
1,981